Skip to main content

and
  1. Article

    Open Access

    TRPC Channels Activated by G Protein-Coupled Receptors Drive Ca2+ Dysregulation Leading to Secondary Brain Injury in the Mouse Model

    Canonical transient receptor potential (TRPC) non-selective cation channels, particularly those assembled with TRPC3, TRPC6, and TRPC7 subunits, are coupled to Gαq-type G protein-coupled receptors for the major c...

    Jasneet Parmar, Georg von Jonquieres in Translational Stroke Research (2024)

  2. No Access

    Article

    Human Brain Region-Specific Alternative Splicing of TRPC3, the Type 3 Canonical Transient Receptor Potential Non-Selective Cation Channel

    Canonical transient receptor potential (TRPC) non-selective cation channels are broadly expressed by neurons, glia and the microvasculature of the brain. In neurons and astrocytes, these ion channels are coupl...

    Jennie M. E. Cederholm, Youngsoo Kim, Georg von Jonquieres in The Cerebellum (2019)

  3. Article

    Open Access

    Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy

    N-Acetylaspartate (NAA) is the second most abundant organic metabolite in the brain, but its physiological significance remains enigmatic. Toxic NAA accumulation appears to be the key factor for ...

    Georg von Jonquieres, Ziggy H. T. Spencer, Benjamin D. Rowlands in Acta Neuropathologica (2018)

  4. Article

    Open Access

    Tau exacerbates excitotoxic brain damage in an animal model of stroke

    Neuronal excitotoxicity induced by aberrant excitation of glutamatergic receptors contributes to brain damage in stroke. Here we show that tau-deficient (tau−/−) mice are profoundly protected from excitotoxic bra...

    Mian Bi, Amadeus Gladbach, Janet van Eersel, Arne Ittner in Nature Communications (2017)

  5. Article

    Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior

    Glucagon-like peptide 1 (GLP-1) and its receptor GLP-1R are a key component of the satiety signaling system, and long-acting GLP-1 analogs have been approved for the treatment of type-2 diabetes mellitus. Prev...

    Anne E Harasta, John M Power, Georg von Jonquieres, Tim Karl in Neuropsychopharmacology (2015)